Question

Mike Martin

Liberal Democrat — Tunbridge Wells

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the National Institute for Health and Care Excellence on the use of encorafenib in combination with cetuximab and chemotherapy as a first-line treatment